Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 39-48, March 2007

Targeted agents in AML: much more to do

  • Richard M. Stone, MD (Clinical Director and Associate Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 617 632 2214; Fax: +1 617 632 2933.

Adult Leukemia Program, Dana Farber Cancer Institute and Harvard Medical School, 44 Binney Street, D 840 Boston, MA 02115, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00086-7

doi:10.1016/j.beha.2006.11.006

Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 39-48, March 2007

Article Tools

* Image Usage & Resolution